| Primary information |
|---|
| sequence ID | Seq_3584 |
| Peptide sequence | HWESASL |
| CancerPDF_ID | CancerPDF_ID8554, CancerPDF_ID11620, |
| PMID | 23667664,26992070 |
| Protein Name | Complement C3f,Complement C3 |
| UniprotKB Entry Name | CO3_HUMAN,CO3_HUMAN |
| Fluid | Serum,Serum |
| M/Z | 828.38,828.37662 |
| Charge | 1,NA |
| Mass (in Da) | 829.89,NA |
| fdr | NA,NA |
| Profiling Technique | MALDI-TOF,LC-MS |
| Peptide Identification technique | FT-ICR MS/MS + nano-HPLC,LC-MS/MS |
| Quantification Technique | NA,NA |
| Labelled/Label Free | Label Free,Label Free |
| FDR | NA,FDR 1 % |
| CancerPDF_ID | CancerPDF_ID8554, CancerPDF_ID11620, |
| p-Value | NA,NA |
| Software | MASCOT,SEQUEST and Maxquant |
| Length | 7,7 |
| Cancer Type | "Breast cancer, Lung cancer, Rectal cancer",Melanoma |
| Database | NA,SwissProt Database |
| Modification | NA,NA |
| Number of Patients | "Breast Cancer =84, lung cancer= 70, Rectal cancer = 30patients; 500 healthy",8 cancer samples and 4 healthy samples |
| Regulation | NA,"Present in 8 cancer samples out of 8 cancer samples. ,Present in 4 healthy samples out of 4 healthy samples." |
| Validation | NA,na |
| Sensitivity | NA,NA |
| Specificity | NA,NA |
| Accuracy | NA,NA |
| Peptide Atlas | NA |
| IEDB | 533899
|